
Geisinger Health Plan President Jeremy Gaskill says being owned by a health system aligns incentives, cuts payer-provider busywork and speeds care to patients.
Supplements And Featured Publications
An in-depth look at multiple myeloma treatment with a focus on bispecific antibodies.
A special Managed Healthcare Executive supplement on the current treatment of multiple myeloma with an emphasis on navigating the use of bispecific antibodies. The referenced article is accompanied by a Q&A with Zahra Mahmoudjafari, Pharm.D., MBA, of the University of Kansas Health System.






